TR
Trulieve Cannabis Corp.
TRLV · NYSE
$12.25 -2.31% (-$0.29)
1M +10.16%
Market Cap $2.13B
P/E Ratio -
Div. Yield -
ROE 44.05%
Piotroski F-Score Moderate
5/9Valuation
89 /100
Cheap P/B 2.78x
P/FCF 11.39x
P/S 1.87x
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
48 /100
Moderate Net margin 41.56%
Op. margin 24.08%
FCF margin 16.40%
Quality
7 /100
Poor ROE 44.05%
ROA 22.79%
Asset turnover 0.55x
Debt
68 /100
Low Current ratio 5.94x
Int. coverage -4.73x
Debt/Equity 0.34x
Stability
12 /100
Unstable Beta 1.76x
EPS volatility N/A
Profitable years N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o TRLV
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Kimberly A. Rivers
Employees
5,000
Headquarters
Tallahassee
Nadchodzące wydarzenia
06 LIS
Earnings
Upcoming earnings report